Study Finds No Increased Cancer Risk With Spironolactone

Over 5 years, treatment with spironolactone for dermatologic conditions was not associated with a greater risk for breast or gynecologic cancers, when compared with women not using spironolactone.

Related Keywords

United States ,New York ,American ,Sharir Lipner ,Rachelc Hill , ,Weill Cornell Medical College ,New York City ,American Academy ,